Market Expansion Opportunity Vapotherm's recent merger and increased focus on advanced high velocity respiratory therapies present an opportunity to expand sales efforts into new clinical settings such as emergency departments and intensive care units, where demand for non-invasive, heated humidified oxygen delivery systems is growing.

Key Stakeholder Engagement Given the company’s active shareholder investigations and recent M&A activity, there is a potential window to communicate strategic value propositions to investors and board members, emphasizing future growth prospects and innovative respiratory solutions to secure interest from institutional buyers.

Technology and Compatibility Vapotherm employs a robust tech stack and scalable systems, signaling opportunities for equipment and software upgrades targeting hospitals already using compatible platforms, as well as bundled solutions integrating with existing health IT infrastructure.

Competitor Benchmarking Aligning sales such as with healthcare providers already using comparable products from Philips, Medtronic, or ResMed, can position Vapotherm as a superior alternative or complementary device, especially in high-demand demographics seeking innovative respiratory therapy.

Growing Clinical Adoption The company’s focus on delivering reliable, non-invasive respiratory support suggests rising adoption in hospitals, emergency services, and outpatient clinics, creating a strategic opportunity to target healthcare systems that are looking to expand their respiratory therapy equipment and service portfolio.